Skip to main content

ScienceDex / Researcher record

Terry Roemer

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #274
  • Rising Star
  • Top 5% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2026

$16.6M
Full award amounts, FY2026
5
Records listing this PI
#274
By linked amount among FY2026 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$1,949,5103#5,609
2025$3,868,4086#2,175
2026$16,558,0115#274

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20243 records
  2. FY20256 records
  3. FY2026 · selected5 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Terry Roemer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NIAID

National Institute of Allergy and Infectious Diseases

$16.6M

5 awards · administering

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12254697Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Microbiology & Immunology

FY2026 award records by amount

NIH award records listing Terry Roemer as a PI. Multi-PI records show the full award amount for context.

  • 5U19AI189168-02U19Contact PI
    Center for accelerated development of drug candidates targeting high threat bacterial infections
    $7.6M
    award amount
  • 5U19AI189183-02U19Contact PI
    Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens
    $7.1M
    award amount
  • 5R44AI165008-03R44Contact PI
    Development of a mechanistically novel synergistic adjuvant to partner with polymyxin antibiotics
    $977.5K
    award amount
  • 5R01AI165740-04R01Contact PI
    Development of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis
    $679.6K
    award amount
  • 5R21AI185171-02R21Contact PI
    Structure-based design of antifungal inhibitors targeting the glycosylphosphatidylinositol (GPI) ethanolamine phosphate transferase, Mcd4
    $204K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Terry Roemer as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Hackensack University Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5609
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #2175
  8. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  9. 2025
    R01 Grant Holder
  10. 2026
    $10M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #274
  12. 2026
    Entered Top 5% Nationally
    Ranked #274